Sign in

CIK 0001759425

  • Large accelerated filer

Mirum Pharmaceuticals, Inc.

Sign in to watch
Ticker
MIRM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831281555
Phone
+1 650-667-4085
Business address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,323,510
in 6 filings, $5.0M under 10b5-1 plans

Net −$7,323,510. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 16 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-10 Vig Pamela Head of Research & Development Grant or award +807 $13.57 $11K 21,242
2022-05-10 Peetz Christopher President and CEO Grant or award +1,500 $13.57 $20K 69,527
2022-05-10 Clements Ian Chief Financial Officer Grant or award +1,125 $13.57 $15K 29,686
2022-01-06 Vig Pamela Chief Scientific Officer Grant or award +10,000 20,435
2022-01-06 Vig Pamela Chief Scientific Officer Grant or award · Stock Option (right to buy) +60,000 60,000
2022-01-06 Radovich Peter Chief Operating Officer Grant or award +10,000 22,231
2022-01-06 Radovich Peter Chief Operating Officer Grant or award · Stock Option (right to buy) +60,000 60,000
2022-01-06 Peetz Christopher President and CEO Grant or award +40,000 68,027
2022-01-06 Peetz Christopher President and CEO Grant or award · Stock Option (right to buy) +240,000 240,000
2022-01-06 Longpre Lara Chief Development Officer Grant or award +10,000 94,998
2022-01-06 Longpre Lara Chief Development Officer Grant or award · Stock Option (right to buy) +60,000 60,000
2022-01-06 Clements Ian Chief Financial Officer Grant or award +10,000 28,561
2022-01-06 Clements Ian Chief Financial Officer Grant or award · Stock Option (right to buy) +60,000 60,000
2021-11-26 Clements Ian Chief Financial Officer Purchase +750 $13.90 $10K 18,561
2021-11-24 Clements Ian Chief Financial Officer Purchase +700 $14.40 $10K 17,811
2021-11-24 Peetz Christopher President and CEO Purchase +7,000 $14.40 $101K 28,027
2021-11-10 Vig Pamela Chief Scientific Officer Grant or award +768 $13.52 $10K 10,435
2021-11-10 Tucker Edwin Jonathan Chief Medical Officer Grant or award +70 $13.52 $946 45,838
2021-11-10 Radovich Peter Chief Operating Officer Grant or award +958 $13.52 $13K 12,231
2021-11-10 Longpre Lara Chief Development Officer Grant or award +753 $13.52 $10K 84,998

Page 27 of 32 · 635 trades